Download PDF
Thromb Haemost 2002; 88(02): 371-373
DOI: 10.1055/s-0037-1613220
Letters to the Editor
Schattauer GmbH

Heparin-platelet Factor 4 Induced Antibodies in Patients with either Autoimmune or Alloimmune Antiphospholipid Antibodies

G. de Larrañaga
1   Section of Biochemistry, Thrombosis and Haemostasis, Hospital of Infectious Diseases FJ Muñiz
,
M. Martinuzzo
2   Division of Haematology, Thrombosis and Haemostasis, Favaloro University, Favaloro Foundation, Buenos Aires, Argentina
,
A. Bocassi
1   Section of Biochemistry, Thrombosis and Haemostasis, Hospital of Infectious Diseases FJ Muñiz
,
M. Migaud Fressart
3   Diagnostica Stago, Paris, France
,
R. Forastiero
2   Division of Haematology, Thrombosis and Haemostasis, Favaloro University, Favaloro Foundation, Buenos Aires, Argentina
› Author Affiliations
Further Information

Publication History

Received 11 February 2002

Accepted after revision 27 March 2002

Publication Date:
07 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Wilson W, Gharavi A, Koike T, Lockshin M, Branch W, Piette J, Brey R, Derksen R, Harris E, Hughes G, Triplett D, Khamashta M. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop. Arthritis Rheum 1999; 42: 1309-11.
    CrossrefPubMedGoogle Scholar
  • 2 Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome?. J Autoimmunity 2000; 15: 163-72.
    CrossrefPubMedGoogle Scholar
  • 3 de Larrañaga G, Forastiero RR, Martinuzzo ME, Carreras LO, Tsariktsian G, Sturno MM, Alonso BS. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus 2000; 09: 594-600.
    CrossrefPubMedGoogle Scholar
  • 4 Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO. Relationship of anti β2 glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997; 78: 1008-14.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 1996; 75: 721-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Lasne D, Saffroy R, Bachelot C, Vincenot A, Rendu F, Papo T, Aiach M, Piette JC. Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndrome. Br J Haematol 1997; 97: 939.
    PubMedGoogle Scholar
  • 7 Wagenknecht DR, McIntyre JA. Interaction of heparin with β2 glycoprotein I and antiphospholipid antibodies in vitro. Thromb Res 1992; 68: 495-500.
    CrossrefPubMedGoogle Scholar
  • 8 Shibata S, Harpet PC, Gharavi A, Rand J, Fillit H. Autoantibodies to heparin from patients with antiphospholipid syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 1994; 83: 2532-40.
    PubMedGoogle Scholar
  • 9 Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: Towards consensus. Thromb Haemost 1998; 79: 1-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Gruel Y. Antiphospholipid syndrome and heparin-induced thrombocytopenia: update on similarities and differences. J Autoinmmunity 2000; 15: 265-8.
    PubMedGoogle Scholar
  • 11 Martinuzzo ME, Forastiero RR, Adamczuk Y, Pombo G, Carreras LO. Antiplatelet factor 4-heparin antibodies in patients with antiphospholipid antibodies. Thromb Res 1999; 95: 271-9.
    CrossrefPubMedGoogle Scholar